Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 16Dermatologic 3Thoracic 2Lymphoid 2Genitourinary 2CNS 2Other hematologic neoplasm 1Other 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Lymphoma 2983Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Lymphoma, Non-Hodgkin 2269Leukemia, Lymphocytic, Chronic, B-Cell 1992Lymphoma, Follicular 1848Lymphoma, Large B-Cell, Diffuse 1785Leukemia 1341Hodgkin Disease 1293Lymphoma, Mantle-Cell 1193Leukemia, Myeloid, Acute 979Burkitt Lymphoma 956Multiple Myeloma 866Lymphoma, B-Cell, Marginal Zone 853Recurrence 841Lymphoma, B-Cell 756Myelodysplastic Syndromes 683Neoplasms 595Lymphoma, T-Cell, Cutaneous 543Waldenstrom Macroglobulinemia 514Lymphoma, Large-Cell, Immunoblastic 490Mycosis Fungoides 438Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Lymphoma, Large-Cell, Anaplastic 390Sezary Syndrome 364Lymphoma, T-Cell, Peripheral 352Hematologic Neoplasms 351Leukemia, Myelogenous, Chronic, BCR-ABL Positive 334Myeloproliferative Disorders 328Neoplasms, Plasma Cell 309Blast Crisis 284

Interventions

efalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Alopecia × Lymphoid × Clear all
NCT00746980 2016-06-14

Efalizumab in the Treatment of Alopecia, Phase II

Northwestern University

Phase 2 Withdrawn
Lymphoid

Alopecia, Lymphoma, Follicular

NCT00129415 2015-05-22

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

University of Michigan

Phase 1/2 Terminated
28 enrolled
DermatologicLymphoid

Alopecia, Dermatitis, Atopic, Mycosis Fungoides, Psoriasis, Skin Diseases, Urticaria, Lymphoma, T-Cell, Cutaneous, Striae Distensae

Data powered by HemOnc (CC BY 4.0) Colophon âš¡